ACM
CLPT icon

Aster Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Aster Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,500
Closed -$269K – 1305
2024
Q4 		$269K Hold
17,500
– – 0.1% 239
2024
Q3 		$196K Buy
+17,500
New +$168K 0.04% 302

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Aster Capital Management's CLPT Position: Q1 2025 in Review

Aster Capital Management sold out of ClearPoint Neuro (CLPT) in Q1 2025, closing a stake of 17,500 shares — an estimated $269K sold.

Aster Capital Management first reported a position in CLPT in Q3 2024 and held it in 2 quarters. The position peaked at $269K in Q4 2024. 101 funds tracked by Wall St. Rank hold CLPT as of Q1 2025.

  • Aster Capital Management reported no remaining ClearPoint Neuro position as of Q1 2025 after selling out during the quarter.
  • Aster Capital Management sold 17,500 ClearPoint Neuro shares in Q1 2025, an estimated $269K.
  • Aster Capital Management first reported a position in ClearPoint Neuro in Q3 2024 and held it in 2 quarters.
  • Aster Capital Management's ClearPoint Neuro position peaked at $269K in Q4 2024.
  • 101 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2025.

Based on Aster Capital Management's 13F filing for Q1 2025, filed 15 May 2025.